Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emmanuelle Rial-Sebbag, Aurélie Mahalatchimy, Anne-Marie Duguet

    Journal International De Bioethique Et D'Ethique Des Sciences
    |March 22, 2018
    PubMed
    Summary
    This summary is machine-generated.

    European Union regulations aim to enhance the use of human biological materials for transplantation, ensuring public health and recipient safety. However, the legal framework for cells remains incompletely harmonized, posing bioethical challenges.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Understanding European Union Substances of Human Origin Case Law through Defragmentation and Fragmentation.

    European journal of health law·2026
    Same author

    Conceptualising European Union Health Law.

    European journal of health law·2026
    Same author

    Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

    EClinicalMedicine·2026
    Same author

    Cascade counselling and testing. Recommendations of the European Society of Human Genetics.

    European journal of human genetics : EJHG·2025
    Same author

    Mapping the European landscape and specificity of ATMPs guidance.

    Cytotherapy·2025
    Same author

    Emerging and evolving values in the changing landscape of genomics.

    Frontiers in genetics·2025
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Chapter 4. Neurotechnologies: striking a balance between scientific progress and privacy

    Journal international de bioethique et d'ethique des sciences·2026
    See all related articles

    Area of Science:

    • Bioethics
    • European Union Law
    • Public Health Policy

    Background:

    • EU directives (2004/23/EC, 2006/17/EC, 2006/86/EC, 2015/565, 2015/566) aim to maximize human biological material use for transplantation.
    • Key objectives include safeguarding public health and ensuring recipient safety through accreditation and personnel training.

    Purpose of the Study:

    • Analyze the qualification of human cells as therapeutic agents (body elements vs. medicinal products) within the EU legal framework.
    • Examine the bioethical dilemmas arising from these qualifications.
    • Assess the impact of cell qualification on safety measures and directive scope.

    Main Methods:

    • Review of EU legislation concerning human biological materials and transplantation.
    • Analysis of legal and ethical frameworks for cell qualification.

    Related Experiment Videos

  • Examination of safety measures and their limitations.
  • Main Results:

    • The EU legal framework for cells, despite comprehensive legislation, exhibits incomplete harmonization.
    • Qualification of human cells as therapeutic agents presents significant bioethical challenges.
    • The scope and effectiveness of safety measures are influenced by cell qualification.

    Conclusions:

    • The EU's approach to human cells as therapeutic agents necessitates addressing complex bioethical issues.
    • Emergence of 'ethical safety' as a critical consideration alongside regulatory safety measures.
    • Further harmonization and clarification of cell qualification are needed for consistent safety and ethical standards.